SYSTEM OPTIMIZATION FOR IMPLANTABLE DEFIBRILLATORS

Information

  • Research Project
  • 2646566
  • ApplicationId
    2646566
  • Core Project Number
    R43HL060412
  • Full Project Number
    1R43HL060412-01
  • Serial Number
    60412
  • FOA Number
  • Sub Project Id
  • Project Start Date
    5/1/1998 - 26 years ago
  • Project End Date
    10/31/1998 - 25 years ago
  • Program Officer Name
  • Budget Start Date
    5/1/1998 - 26 years ago
  • Budget End Date
    10/31/1998 - 25 years ago
  • Fiscal Year
    1998
  • Support Year
    1
  • Suffix
  • Award Notice Date
    4/20/1998 - 26 years ago
Organizations

SYSTEM OPTIMIZATION FOR IMPLANTABLE DEFIBRILLATORS

DESCRIPTION (Adapted from applicant's abstract): The overall objective of the proposed research is to reduce the amount of energy required for ventricular defibrillation, thereby permitting significant size reductions in an implantable cardioverter defibrillator without compromising defibrillation safety margins. This will be attempted by a Systems approach that includes optimization of the biphasic waveform, specifically targeting the use of small capacitors with values less than 95microF; identifying the most efficacious electrode locations and current pathways; and studying the effects of shock timing on defibrillation threshold. The efficacy of small capacitor biphasic waveforms with varying durations and tilts in combination with high voltage changes at phase reversal will be compared in anesthetized pigs. The influence of electrode size, shape, and location on current distribution and voltage gradients in the heart will be examined using a realistic finite element model of the human thorax. These results will form the basis for additional electrode placement and current pathway studies in humans. Since small capacitors have the advantage of delivering therapy earlier due to faster charging times, we will investigate whether the early delivery of a defibrillation shock as well as the timing of the shock within the fibrillation cycle would provide additional reductions in defibrillation threshold. PROPOSED COMMERCIAL APPLICATION: Proposed commercial application not available.

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    R43
  • Administering IC
    HL
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    837
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    ZRG7
  • Study Section Name
  • Organization Name
    ANGEION CORPORATION
  • Organization Department
  • Organization DUNS
  • Organization City
    BROOKLYN PARK
  • Organization State
    MN
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    55428
  • Organization District
    UNITED STATES